InvestorsHub Logo
Followers 0
Posts 342
Boards Moderated 0
Alias Born 08/12/2009

Re: None

Friday, 09/18/2009 4:04:54 PM

Friday, September 18, 2009 4:04:54 PM

Post# of 334625
FDA approval is the only thing holding this back. BIEL was at a 52 week low as of .001 on March 10th, and since has climbed to a 52 week high of .122 on September 11th. We're talking about a 3000 + % gain in 7 months folks, with the vast majority of that gain happening after early May. It's not uncommon for pinks to run up big gains and then get dumped, but that usually happens very quickly, in a much shorter period of time. Though the runup of this stock pretty much has occurred on pure speculation and anticipation, void of any real notable news as a driving factor, it nevertheless appears to have legs. BIEL appears to have a genuine product that can revolutionize the treatment of pain management, and investors are banking on that. If BIEL and it's products were a scam, and this runup were part of some pump and dump scheme, I think they would have been exposed by now, with the PPS taking a nose dive some time ago. It appears that BIEL is a genuine speculative play here folks. No doubt that anticipation is driving this stock, and as long as FDA approval is thought to be just around the corner, the runup will be sustainable. If this stock has moved this far on just forward looking statements by the company think of what the PPS will look like when they receive FDA approval, along with the humongous jumps in revenues they will receive once their PEMF devices have hit all those untapped markets. I own this stock and I'm not trying to pump it, I hate those scumbags, but's let's be real, if that FDA approval comes through it will impact the PPS much more than people think. If you can tolerate the risks from here on in, I think the rewards will end up being huge, IMO of course.